Home » Stocks » Avedro

Avedro, Inc. (AVDR)

Nov 21, 2019 - AVDR merged into GKOS
Stock Price: $22.99 USD 0.00 (0.00%)
Updated Jan 6, 2020 4:00 PM EST

Stock Price Chart

Key Info

Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jan 6, 2020
Last Price $22.99
Previous Close $22.99
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 22.99 - 22.99
Day's Volume 0
52-Week Range 10.75 - 27.51

More Stats

Market Cap n/a
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding n/a
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 32.21M
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

Current: $22.99
Target: 26.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth37.3%35.17%-
Gross Profit16.7910.307.77
Operating Income-21.25-18.97-14.92
Net Income-25.12-21.28-16.38
Shares Outstanding1.401.321.13
Earnings Per Share-17.97-16.12-14.50
Operating Cash Flow-22.18-24.00-12.81
Capital Expenditures-0.36-0.82-0.44
Free Cash Flow-22.54-24.81-13.26
Cash & Equivalents10.329.4013.15
Total Debt19.9419.329.62
Net Cash / Debt-9.62-9.923.52
Book Value-73.59-49.52-29.31
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avedro, Inc.
Employees 122
CEO Reza Zadno

Stock Information

Ticker Symbol AVDR
Stock Exchange NASDAQ
Sector Health Technology
Industry Medical Specialties
Unique Identifier NASDAQ: AVDR
IPO Date February 14, 2019


Avedro, an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Avedro sells its products primarily to ophthalmologists, hospitals, and ambulatory surgery centers through a direct sales force in the United States, as well as through medical device distributors internationally. The company was formerly known as ThermalVision, Inc. and changed its name to Avedro, Inc. in October 2005. Avedro, Inc. was incorporated in 2002 and is headquartered in Waltham, Massachusetts.